Form 8-K uniQure N.V. For: Nov 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
uniQure BV (QURE) PT Raised to $72 at B.Riley/FBR
November 15, 2018 9:58 AM ESTB.Riley/FBR analyst Madhu Kumar raised the price target on uniQure BV (NASDAQ: QURE) to $72.00 (from $50.00) while maintaining a Buy rating.
... MoreuniQure BV (QURE) PT Raised to $65 at Cantor Fitzgerald
November 15, 2018 9:36 AM ESTCantor Fitzgerald analyst Elemer Piros raised the price target on uniQure BV (NASDAQ: QURE) to $65.00 (from $58.00) while maintaining a Overweight rating.
Piros commented, "This morning, uniQure announced initial top-line data from the Phase 2b dose-confirmation study of AMT-061 for the treatment of... More
